Japan at Record High Ahead of Ukraine Talks
Asia-Pacific markets mostly rose Monday as investors awaited talks between U.S. President Donald Trump and his Ukrainian counterpart, Volodymyr Zelenskyy.
The U.S.-Russia summit on ending the conflict between Kyiv and Moscow concluded without a ceasefire deal on Friday.
In Japan, the Nikkei sparked higher 336 points, or 0.8%, to 43,3714.31.
The best-performing stocks were , which surged 10.2%, , which advanced 7.79% and CyberAgent Inc, which added 7.67%, according to LSEG data.
In Hong Kong, the Hang Seng retreated 93.22 points, or 0.4%, to 25,176.85.
Taiwan stocks topped its previous record close in July 2024.
In Singapore, non-oil domestic exports shrank 4.6% in July from the year before, worse than the 1.8% contraction penciled in by economists polled by Reuters.
July’s reading comes after a revised growth rate of 12.9% in June, data from Enterprise Singapore showed Monday.
CHINA
In Shanghai, the CSI 300 gained 37.06 points, or 0.9%, to 4,239.41, its highest level since October 2024.
In other markets
In Singapore, the Straits Times index dipped 43.15 points, or 1%, to 4,187.38
In Korea, the Kospi returned from a long weekend to gain 48.38 points, or 1.5%, 3,177.28.
In Taiwan, the Taiex index zoomed 148.04 points, or 0.6%, to 24,482.52.
In New Zealand, the NZX 50 tacked on 81.26 points, or 0.6%, to 12,970.64
In Australia, the ASX 200 added 20.71 points, or 0.2%, to 8,959.27
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


